[Post myocardial infarction management].
Post myocardial infarction preventive strategies are effective in reducing morbidity and mortality. Life threatening risk factors can be controlled by medication in addition to dietary measures. The following update will be proposed on: new lipidic and non lipidic risk factors; necessity to control risk factors, nicotine dependence and lipid metabolism disorders in particular; patient follow-up; drug treatment efficacy (beta-blockers, aspirin, ACEI, statins); compliance to a varied drug treatment regimen. Three newly developed treatments will be presented: the first sartan, clopidogrel and troglitazone.
Sternon
J
J
Service de Médecine Interne, Hôpital Erasme, Bruxelles et C.U.M.G.-U.L.B.
D000359:Aftercare / Q000379:methods*; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D000975:Antioxidants / Q000627:therapeutic use; D000069059:Atorvastatin; D002839:Chromans / Q000627:therapeutic use; D000077144:Clopidogrel; D018752:Diet, Fat-Restricted; D006538:Heptanoic Acids / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000209:etiology / Q000517:prevention & control*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011758:Pyrroles / Q000627:therapeutic use; D012307:Risk Factors; D013844:Thiazoles / Q000627:therapeutic use; D045162:Thiazolidinediones; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000077288:Troglitazone
D000924:Anticholesteremic Agents; D000975:Antioxidants; D002839:Chromans; D006538:Heptanoic Acids; D010975:Platelet Aggregation Inhibitors; D011758:Pyrroles; D013844:Thiazoles; D045162:Thiazolidinediones; D000069059:Atorvastatin; D000077144:Clopidogrel; D000077288:Troglitazone; D013988:Ticlopidine